| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2400544 | Medical Mycology Case Reports | 2014 | 4 Pages |
Abstract
The existing guidelines regarding the management of invasive pulmonary aspergillosis do not recommend screening of the extra-pulmonary sites. Due to the fact that the presence of central nervous system (CNS) aspergillosis will influence treatment decisions regarding which antifungal to use and the aimed target concentrations of azoles in plasma, to be informed about dissemination of the infection to the CNS is absolutely necessary. We demonstrate the need for a structured approach to screening of pediatric patients for CNS aspergillosis.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
Emmi Broenen, Annelies Mavinkurve-Groothuis, Karin Kamphuis-van Ulzen, Roger Brüggemann, Paul Verweij, Adilia Warris,